GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alliance Pharma PLC (LSE:APH) » Definitions » 12-1 Month Momentum %

Alliance Pharma (LSE:APH) 12-1 Month Momentum % : -34.53% (As of Apr. 29, 2024)


View and export this data going back to 2001. Start your Free Trial

What is Alliance Pharma 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-04-29), Alliance Pharma's 12-1 Month Momentum % is -34.53%.

The industry rank for Alliance Pharma's 12-1 Month Momentum % or its related term are showing as below:

LSE:APH's 12-1 Month Momentum % is ranked worse than
79.44% of 1114 companies
in the Drug Manufacturers industry
Industry Median: -5.73 vs LSE:APH: -34.53

Competitive Comparison of Alliance Pharma's 12-1 Month Momentum %

For the Drug Manufacturers - Specialty & Generic subindustry, Alliance Pharma's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alliance Pharma's 12-1 Month Momentum % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Alliance Pharma's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Alliance Pharma's 12-1 Month Momentum % falls into.



Alliance Pharma  (LSE:APH) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Alliance Pharma  (LSE:APH) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Alliance Pharma 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Alliance Pharma's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Alliance Pharma (LSE:APH) Business Description

Traded in Other Exchanges
Address
Bath Road, Avonbridge House, Chippenham, Wiltshire, GBR, SN15 2BB
Alliance Pharma PLC is a player in the healthcare market. The company's business includes the acquisition, marketing, and distribution of consumer healthcare and pharmaceutical products. The group operates in two segments: Consumer Healthcare brands and Prescription Medicines. It generates the majority of its revenue from the Consumer Healthcare segment. Its products include Aloclair, Biodermatin, Changmin, Decapional, Effadiane, and Fazol. The company generates maximum revenue from the Kelo-cote brand. Geographically, it derives a majority of its revenue from Europe, the Middle East, and Africa (EMEA).

Alliance Pharma (LSE:APH) Headlines

From GuruFocus

Q3 2021 Amphenol Corp Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q4 2022 Amphenol Corp Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q4 2020 Amphenol Corp Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q1 2021 Amphenol Corp Earnings Call Transcript

By GuruFocus Research 01-22-2024

The Amphenol Corp (APH) Company: A Short SWOT Analysis

By GuruFocus Research 10-30-2023

Q2 2019 Amphenol Corp Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q2 2021 Amphenol Corp Earnings Call Transcript

By GuruFocus Research 01-22-2024

Amphenol Announces Third Quarter 2023 Dividend

By Business Wire 08-04-2023

Q2 2023 Amphenol Corp Earnings Call Transcript

By GuruFocus Research 01-22-2024